Oligometastatic Malignant Neoplasm — Trials

Oligometastatic Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 6%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07578116	Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis	not yet recruiting	Phase 3	562	SWOG Cancer Research NetworkNETWORK	0	May 27, 2026	clinicaltrials

Data updated 22 days agoSource updated May 27, 2026source: clinicaltrials